• Data
    • Overview
    • Clinical notes
    • Images
    • Mother-child
    • Oncology
    • Regulatory grade
    • Truveta Language Model
    • Truveta Studio
  • Genomics
  • Solutions
    • Life science
    • Public health
    • Healthcare
  • Research
  • Resources
  • About
    • Blog
    • Members
    • Leadership
    • Events & webinars
    • Newsroom
    • Careers
Get started
Sign in
Double play: Multi-injury athletes, by the numbers

Double play: Multi-injury athletes, by the numbers

by Truveta Research | Apr 21, 2023 | Research, Research Insights

With over 3.5 million sport injuries estimated to occur each year (Johns Hopkins Medicine, 2023), we spent the last several weeks digging into and describing injury patterns related to specific sports: basketball, soccer, baseball/softball, and football. Although...
How does approval of a new Alzheimer’s drug impact genetic testing?

How does approval of a new Alzheimer’s drug impact genetic testing?

by Truveta Research | Apr 21, 2023 | Research, Research Insights

The National Institute of Health estimates that more than six million Americans over the age of 65 suffer from Alzheimer’s disease, with many more under the age of 65 also having the disease (National Institute on Aging, 2021). It is currently ranked as the seventh...

Share this


Recent posts

  • Truveta experts: Gestational diabetes screening in real-world practice
  • Non-small cell lung cancer: Biomarkers, treatments, and outcomes in real-world data
  • Johns Hopkins builds research community to explore new frontiers in health using Truveta Data

Follow Truveta


Sign up for our newsletter

Ready to accelerate your research with representative, complete, and timely real-world data?

Truveta Data

Truveta Genome Project

Solutions

Research

Resources

Blog

Newsroom

Careers

Privacy notice

Contact us

© Truveta 2025

Our website uses cookies to ensure you have the best experience.